CHO Pharma Statistics
Total Valuation
CHO Pharma has a market cap or net worth of TWD 12.95 billion. The enterprise value is 10.49 billion.
Market Cap | 12.95B |
Enterprise Value | 10.49B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CHO Pharma has 214.01 million shares outstanding. The number of shares has increased by 12.15% in one year.
Shares Outstanding | 214.01M |
Shares Change (YoY) | +12.15% |
Shares Change (QoQ) | +7.73% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 11.45% |
Float | 183.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11,536.99 |
PB Ratio | 4.50 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -41.11 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -41.93 |
Financial Position
The company has a current ratio of 23.43, with a Debt / Equity ratio of 1.25.
Current Ratio | 23.43 |
Quick Ratio | 23.03 |
Debt / Equity | 1.25 |
Debt / EBITDA | n/a |
Debt / FCF | -0.14 |
Interest Coverage | -594.40 |
Financial Efficiency
Return on equity (ROE) is -12.29% and return on invested capital (ROIC) is -6.91%.
Return on Equity (ROE) | -12.29% |
Return on Assets (ROA) | -6.52% |
Return on Capital (ROIC) | -6.91% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.08% in the last 52 weeks. The beta is 0.12, so CHO Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.12 |
52-Week Price Change | -20.08% |
50-Day Moving Average | 62.33 |
200-Day Moving Average | 62.41 |
Relative Strength Index (RSI) | 46.41 |
Average Volume (20 Days) | 210,639 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHO Pharma had revenue of TWD 1.08 million and -255.25 million in losses. Loss per share was -1.24.
Revenue | 1.08M |
Gross Profit | 548,000 |
Operating Income | -231.82M |
Pretax Income | -255.25M |
Net Income | -255.25M |
EBITDA | -217.21M |
EBIT | -231.82M |
Loss Per Share | -1.24 |
Balance Sheet
The company has 2.49 billion in cash and 35.95 million in debt, giving a net cash position of 2.45 billion or 11.47 per share.
Cash & Cash Equivalents | 2.49B |
Total Debt | 35.95M |
Net Cash | 2.45B |
Net Cash Per Share | 11.47 |
Equity (Book Value) | 2.88B |
Book Value Per Share | 13.44 |
Working Capital | 2.43B |
Cash Flow
In the last 12 months, operating cash flow was -245.44 million and capital expenditures -4.85 million, giving a free cash flow of -250.29 million.
Operating Cash Flow | -245.44M |
Capital Expenditures | -4.85M |
Free Cash Flow | -250.29M |
FCF Per Share | -1.17 |
Margins
Gross Margin | 50.65% |
Operating Margin | -21,424.77% |
Pretax Margin | -23,590.94% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -23,132.16% |
Dividends & Yields
CHO Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.15% |
Shareholder Yield | -12.15% |
Earnings Yield | -2.05% |
FCF Yield | -1.93% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |